Health Care Quality Illusions

David Lazarus is a reporter on consumer issues for the LA Times. His family recently became big-time consumers of health when his wife spent a

READ MORE

The monoclonal antibody revolution

Generic entry for small molecule drugs is controlled by Hatch-Waxman, allowing generic entry 10 – 20 years after FDA approval. For monoclonal antibodies and other

READ MORE
Subscribe

Email Address*